TYRON TRACY: Open Payments
NPI 1295176923 · BEAVERTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,132 in 92 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,189 · 2025 $2,132
Food & beverage: $2,132
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $459 |
| CSL Behring | 19 | $431 |
| Novartis Pharmaceuticals Corporation | 14 | $306 |
| Amgen Inc. | 8 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $151 |
| Genentech USA, Inc. | 5 | $127 |
| GlaxoSmithKline, LLC. | 4 | $99 |
| Pharming Healthcare, Inc. | 3 | $67 |
| Ionis Pharmaceuticals, Inc. | 2 | $63 |
| Cycle Pharmaceuticals Inc | 2 | $56 |
Products named: TEZSPIRE, Hizentra, Xolair, AIRSUPRA, Rhapsido, Andembry, Haegarda, NUCALA.
Industry payments across OR — which companies pay providers there.
